PHILADELPHIA, Sept. 22 /PRNewswire/ -- The recovery that began in the
private equity markets in 2003 continues in full force in 2004 and the Greater
Philadelphia region is once again experiencing a renaissance of venture
investment, interest, and excitement. This will be evident at the upcoming
2004 Mid-Atlantic Venture Conference (MAVC), where approximately 60 of the
most promising local, national, and international life sciences and technology
companies will receive unrivaled access to investors.
The Greater Philadelphia Venture Group (GPVG), the region's leading
private equity association, today announces its selection of 60 top-tier
entrepreneurs seeking funding as "Featured Companies" for the 2004 MAVC. At
the Venture Conference, these companies will present their business plans to
over 320 of the country's most prominent investment firms in hopes of securing
critical growth capital.
"The private equity market is back in Greater Philadelphia. With over
$1 billion of new growth capital ready for deployment in the region, and a 10%
increase in invested capital last year, investors in Philadelphia and the
Mid-Atlantic region are eager to find promising new companies," says Steve
Crane, Leader of Emerging and Growth Markets Practice, Ernst & Young, LLP, and
Chairman of the 2004 MAVC. "This year's impressive slate of Featured
Companies is sure to attract the interest of our attendees."
The East Coast's largest and most prestigious private equity event, the
2004 MAVC expects over 1,200 attendees on October 25, 26 & 27, at the
Pennsylvania Convention Center, in Philadelphia. At this year's MAVC, life
science companies comprise half of the Featured Companies, demonstrating the
accelerating growth of the Philadelphia region's biotech industry as a
regional economic driver.
About half of the Featured Companies at this year's Venture Conference are
from the Greater Philadelphia region, with the rest hailing from national and
international locations as distant as Washington State, Massachusetts, North
Carolina, Ireland, and Japan. Some of the life sciences and technology
companies attending the 2004 Mid-Atlantic Venture Conference include:
-- Octagon Research Solutions Inc., King of Prussia, Pa., a
process-centric solutions provider that offers a suite of clinical
data management, statistical, and information technology services to
the life sciences industry. Octagon represents a number of Featured
Companies at the 2004 MAVC that are growing the Philadelphia region's
biotechnology industry through service offerings to prominent
-- Mediaguide, Berwyn, Pa., a technology-based media and marketing
information company that electronically monitors radio broadcasts
throughout the country to produce charts and airplay data products
for the music industry. Mediaguide exemplifies various media
companies being highlighted in the technology track at this year's
-- Sopherion Therapeutics, relocating from New Haven, Conn. to
Princeton, N.J. in October, acquires, discovers, designs and develops
therapeutic anti-cancer agents. Sopherion's relocation is a
testament to the Greater Philadelphia region's economic draw.
-- TMG Health Inc., King of Prussia, Pa., a provider of operational
outsourcing solutions and information systems for health plans,
providers, and insurers that focuses on the Medicare and Medicaid
market. TMG Health is one of several companies at this year's MAVC
with a comprehensive national outlook - in this case addressing one
of the largest healthcare issues facing the country today, the cost
of healthcare for seniors and the underprivileged.
-- H & T Corporation, Higashi-Osaka, Japan, a provider of medical
information system, network construction, and software engineering
technology. H & T will travel the farthest distance from Japan to
Philadelphia, demonstrating the international reach that the MAVC has
gained over its 15-year history.
"This year's participating companies all have one thing in common: sound
visions for success that will transform the technology and life sciences
industries both here in Philadelphia, and around the world," says Bruce
Luehrs, General Partner, Edison Venture Fund, and Chairman of the Selection
Committee for the 2004 MAVC. "We're proud to give these entrepreneurs the
unique opportunity to meet hundreds of top investors, secure vital funding to
grow their businesses, and spur economic growth for their local economies.
MAVC Featured Companies have raised over $2 billion in the past five years,
and the companies at this year's Venture Conference will continue that
impressive track record."
For more information about the 2004 Mid-Atlantic Venture Conference,
please visit http://www.mavc.org. Media can contact Kristy Lash at
610-642-8253 or email email@example.com.
The Mid-Atlantic Venture Conference (MAVC), the largest and most
prestigious private equity event on the East Coast, will be held October 25,
26 & 27, 2004, at the Pennsylvania Convention Center, Philadelphia.
Throughout its 15-year history, the MAVC has prided itself on the quality of
its audience, comprised of premier private equity investors, Featured
Companies, investment bankers, commercial lenders and service providers.
Attracting over 1,200 attendees, including 320 investors from across the
country, the 2004 MAVC expects to highlight 60 Featured Companies,
representing the highest quality investment opportunities from the Mid-
Atlantic area and beyond.
As the MAVC's host, the Greater Philadelphia Venture Group (GPVG) reaches
up to New England, down to the Southeast, and out to the Midwest, to highlight
the most promising emerging and growth companies, from follow-on to pre-IPO
investments. From 1998 to 2003, MAVC Featured Companies have raised over
$2.0 billion in early to later stage funding. Beyond the Featured Companies,
the MAVC offers high value networking opportunities and timely and topical
programs, including dynamic speakers and lively panel discussions. As always,
the MAVC will feature robust technology and life sciences tracks, presenting
exciting companies in areas including IT, nanotechnology, telecommunications,
medical devices, biotechnology, and specialty pharmaceuticals, making the MAVC
the private equity event not to be missed. For additional information, please
SOURCE Greater Philadelphia Venture Group